Portfolio company
iOmx Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
Deep Tech
About
This biopharmaceutical company develops cancer immunotherapies targeting novel immune checkpoints to treat patients with tumours resistant to current treatments.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.